HealthEquity, Inc. (NASDAQ:HQY) major shareholder Berkley Capital, Llc sold 1,100 shares of the stock in a transaction dated Monday, October 9th. The shares were sold at an average price of $51.95, for a total transaction of $57,145.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Berkley Capital, Llc also recently made the following trade(s):

  • On Friday, October 6th, Berkley Capital, Llc sold 29,032 shares of HealthEquity stock. The shares were sold at an average price of $51.97, for a total transaction of $1,508,793.04.
  • On Thursday, October 5th, Berkley Capital, Llc sold 286,512 shares of HealthEquity stock. The shares were sold at an average price of $51.96, for a total transaction of $14,887,163.52.
  • On Friday, July 14th, Berkley Capital, Llc sold 72,791 shares of HealthEquity stock. The shares were sold at an average price of $51.41, for a total transaction of $3,742,185.31.

HealthEquity, Inc. (HQY) traded down 0.04% during midday trading on Wednesday, reaching $51.32. 293,380 shares of the company traded hands. The company’s 50-day moving average price is $46.41 and its 200 day moving average price is $46.70. The firm has a market capitalization of $3.10 billion, a PE ratio of 76.14 and a beta of 1.80. HealthEquity, Inc. has a 12 month low of $30.34 and a 12 month high of $54.95.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, September 5th. The company reported $0.27 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.14 by $0.13. The firm had revenue of $56.90 million during the quarter, compared to analysts’ expectations of $55.66 million. HealthEquity had a return on equity of 13.93% and a net margin of 20.27%. HealthEquity’s quarterly revenue was up 28.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.16 EPS. On average, equities analysts anticipate that HealthEquity, Inc. will post $0.71 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “HealthEquity, Inc. (HQY) Major Shareholder Sells $57,145.00 in Stock” was originally reported by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another website, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The legal version of this article can be accessed at https://www.americanbankingnews.com/2017/10/11/healthequity-inc-hqy-major-shareholder-sells-57145-00-in-stock.html.

HQY has been the subject of several recent analyst reports. BidaskClub cut shares of HealthEquity from a “buy” rating to a “hold” rating in a research report on Monday, July 24th. Zacks Investment Research upgraded shares of HealthEquity from a “hold” rating to a “buy” rating and set a $54.00 price objective for the company in a research report on Wednesday, July 12th. TheStreet upgraded shares of HealthEquity from a “c” rating to a “b” rating in a research report on Monday, July 31st. Cantor Fitzgerald restated a “buy” rating and set a $56.00 price objective on shares of HealthEquity in a research report on Tuesday, September 5th. Finally, Robert W. Baird restated a “hold” rating on shares of HealthEquity in a research report on Thursday, September 21st. Two research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $57.17.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Fifth Third Bancorp boosted its holdings in HealthEquity by 382.8% in the 1st quarter. Fifth Third Bancorp now owns 2,414 shares of the company’s stock worth $102,000 after acquiring an additional 1,914 shares during the period. Oppenheimer Asset Management Inc. purchased a new position in shares of HealthEquity during the 1st quarter valued at approximately $106,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of HealthEquity by 105.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,544 shares of the company’s stock valued at $127,000 after buying an additional 1,308 shares during the last quarter. Riverhead Capital Management LLC boosted its stake in shares of HealthEquity by 75.3% during the 2nd quarter. Riverhead Capital Management LLC now owns 2,629 shares of the company’s stock valued at $131,000 after buying an additional 1,129 shares during the last quarter. Finally, Exane Derivatives purchased a new position in shares of HealthEquity during the 2nd quarter valued at approximately $132,000. Hedge funds and other institutional investors own 90.97% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.